The Breville Group Ltd (ASX: BRG) share price is going nuts! Time to buy BRG?
The Breville Group Ltd (ASX: BRG) share price is going nuts. Could it be time to load up on Breville shares? This analysts like BRG shares.
Looking for growth in 2020 and beyond? Here are the latest ASX growth stock ideas, stories and news from our team at Rask Media. We think it’s fair to say that Australia’s ASX growth stocks are some of the best in the world, given their potential for international growth and the fact that many Australian companies also offer their dividends with franking credits.
The Breville Group Ltd (ASX: BRG) share price is going nuts. Could it be time to load up on Breville shares? This analysts like BRG shares.
The A2 Milk Company Ltd (ASX:A2M) share price has sunk more than 10% as investors absorbed the weak outlook commentary.
Sociedad Quimica y Minera de Chile (NYSE: SQM) is the world’s second-largest producer of lithium chemicals. Its 2Q23 report stunned the market by missing analyst profit expectations by ~20%, sending its shares lower.
Over the past 5 days, the GUD Holdings Limited (ASX: GUD) share price has jumped 12.5%. But that’s no surprise to the team at Stock Doctor. Analyst Daniel Ortisi explains why this week’s news means for GUD shareholders.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
The Temple & Webster Group Ltd (ASX:TPW) share price fell 5% as the online ASX retail share reported an overall decline in FY23, but a stronger second half.
The Pro Medicus Ltd (ASX:PME) share price has gained another 5% following the FY23 result which included more impressive growth.
The CSL Ltd (ASX:CSL) share price is up more than 3% after reporting its FY23 result and guiding more growth for FY24.
The Carsales.Com Ltd (ASX:CAR) share price has shot up more than 5% after the car online marketplace revealed a strong FY23 result.
The Breville Group Ltd (ASX: BRG) share price is going nuts. Could it be time to load up on Breville shares? This analysts like BRG shares.
The A2 Milk Company Ltd (ASX:A2M) share price has sunk more than 10% as investors absorbed the weak outlook commentary.
Sociedad Quimica y Minera de Chile (NYSE: SQM) is the world’s second-largest producer of lithium chemicals. Its 2Q23 report stunned the market by missing analyst profit expectations by ~20%, sending its shares lower.
Over the past 5 days, the GUD Holdings Limited (ASX: GUD) share price has jumped 12.5%. But that’s no surprise to the team at Stock Doctor. Analyst Daniel Ortisi explains why this week’s news means for GUD shareholders.
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in.
The Temple & Webster Group Ltd (ASX:TPW) share price fell 5% as the online ASX retail share reported an overall decline in FY23, but a stronger second half.
The Pro Medicus Ltd (ASX:PME) share price has gained another 5% following the FY23 result which included more impressive growth.
The CSL Ltd (ASX:CSL) share price is up more than 3% after reporting its FY23 result and guiding more growth for FY24.
The Carsales.Com Ltd (ASX:CAR) share price has shot up more than 5% after the car online marketplace revealed a strong FY23 result.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024